Article
New and Emerging Treatments for Cystic Fibrosis.
Drugs - 1 Jul 2015
Barry Peter J, Jones Andrew M
Abstract excerpt
Recently, a significant number of additional key medications have become licensed in Europe for the treatment of patients with cystic fibrosis (CF), including a number of inhaled antibiotics, such as nebulised aztreonam and dry powder versions of colistin and tobramycin for inhalation; dry powder inhaled mannitol, an agent to improve airway hydration and aid airway clearance; and ivacaftor, an oral therapy that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
